NCT06769776 Drain vs No Drain After Live Donor Hepatectomy
| NCT ID | NCT06769776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marengo Asia Hospitals |
| Condition | Donor Hepatectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-08-02 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-08-02 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prophylactic abdominal drain placement after donor hepatectomy has been a common or even mandatory practice in most transplant centers. This serves to monitor the occurrence of post-operative intra-abdominal bleeding and is used for the detection and drainage of any bile leakage. However prophylactic drain placement is not without complications, like; Increased rates of intraabdominal and wound infection, Increased abdominal pain, Decreased pulmonary function, Bowel injury and Prolonged hospital stay. Comprehensive Complication Index (CCI) is a valuable tool used to assess the overall morbidity of patients after surgical interventions . The CCI score ranges from 0 (no complication) to 100 (death), reflecting the gravity of the overall complication burden on the patient on a continuous scale and is a validated tool for living donor liver transplants. The investigators aim to compare the safety of no drain placement vs abdominal drain placement in LDLT(Live Donor Liver Transplant) by comparing the comprehensive complication index(CCI) between both arms at day of discharge after donor hepatectomy.
Eligibility Criteria
Inclusion Criteria: Patients undergoing donor hepatectomy - Exclusion Criteria: Any patient not consenting to the procedure. Intraoperative need for drain placement in no drain arm due to surgical factors. Inverted L/ J shaped incision. Laparoscopic donor hepatectomy Robotic donor hepatectomy. \-
Contact & Investigator
Punit Singla, MS,DNB
STUDY DIRECTOR
Marengo Asia Hospitals
Frequently Asked Questions
Who can join the NCT06769776 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Donor Hepatectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769776 currently recruiting?
Yes, NCT06769776 is actively recruiting participants. Contact the research team at bharatarcher1@gmail.com for enrollment information.
Where is the NCT06769776 trial being conducted?
This trial is being conducted at Faridabad, India.
Who is sponsoring the NCT06769776 clinical trial?
NCT06769776 is sponsored by Marengo Asia Hospitals. The principal investigator is Punit Singla, MS,DNB at Marengo Asia Hospitals. The trial plans to enroll 80 participants.